ArticleNucleic acids research2026
Functional analyses identify the L1 ORF2p Cryptic domain as a hub for intramolecular interfaces required for retrotransposition.
Article in Nucleic acids research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Endonuclease (EN) and reverse transcriptase (RT) functions of Long Interspersed Element-1 (L1) ORF2p are required for DNA-nicking and complementary DNA (cDNA) synthesis during retrotransposition. These domains are homologous to cellular/viral proteins and are well-studied. The ORF2p Cryptic region has no known homologues, is evolutionarily conserved among L1-like elements, and is required for retrotransposition through an unknown mechanism. While ORF2p structures establish Cryptic interactions with the EN, RT, and C-terminal domains (CTD), functional importance of these interactions remains unclear. We examine functional contributions of these intramolecular interactions in retrotransposition through mutagenesis, co-immunoprecipitation, cDNA synthesis, RNA binding, retrotransposition, cytotoxicity, and molecular modeling analyses. We demonstrate that Cryptic functions as an independent domain capable of reestablishing functional intramolecular interactions in trans to rescue cDNA synthesis. The Cryptic:RT interface is required for cDNA initiation/elongation and may also affect EN function in retrotransposition, while eliminating ORF2p toxicity. In contrast, the Cryptic:CTD interface is not required for first strand cDNA synthesis but affects retrotransposition and increases ORF2p toxicity. Overall, intramolecular interactions involving Cryptic are required for multiple steps of retrotransposition and propose Cryptic as a nonenzymatic structural domain and a promising target for therapeutic interventions in cancers with upregulated L1 expression.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.